Manuel Lopez-Figueroa
Directeur/Membre du Conseil chez ORYZON GENOMICS S.A.
Postes actifs de Manuel Lopez-Figueroa
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ORYZON GENOMICS S.A. | Directeur/Membre du Conseil | 11/05/2020 | - |
| Independent Dir/Board Member | 11/05/2020 | - | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Consultant / Advisor | 07/07/2021 | - |
| Private Equity Investor | 01/07/2001 | 01/07/2021 | |
Imidomics, Inc.
 Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Directeur des opérations | 01/06/2015 | - |
| Cantero Therapeutics, Inc. | Directeur/Membre du Conseil | 01/01/2018 | - |
| Fondateur | 01/01/2018 | - | |
| Zulia Biotech, Inc. | Directeur/Membre du Conseil | - | - |
Nina Capital SGEIC SA
 Nina Capital SGEIC SA Investment ManagersFinance Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain. | Consultant / Advisor | 01/01/2019 | - |
Historique de carrière de Manuel Lopez-Figueroa
Formation de Manuel Lopez-Figueroa
| University of Copenhagen | Doctorate Degree |
| La Laguna University Of | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Espagne | 4 |
| Danemark | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Consultant / Advisor | 2 |
| Private Equity Investor | 1 |
Sectorielle
| Finance | 3 |
| Consumer Services | 3 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Health Technology |
| Cantero Therapeutics, Inc. | |
| Zulia Biotech, Inc. | |
Nina Capital SGEIC SA
Nina Capital SGEIC SA Investment ManagersFinance Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain. | Finance |
- Bourse
- Insiders
- Manuel Lopez-Figueroa
- Expérience
